Journal Information
Most cited
29
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
29
Open access
28
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysisDaniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
28
Open access
23
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter studyKe Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han
Ann Hepatol. 2023;28:101109
23
Full text access
18
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized studySamantha Thifani Alrutz Barcelos, Amanda Souza Silva-Sperb, Helena Abadie Moraes, Larisse Longo, Bruna Concheski de Moura, Matheus Truccolo Michalczuk, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, ... Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100769
18
Open access
17
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver diseaseDongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao
Ann Hepatol. 2023;28:100726
17
Full text access
17
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research networkMarina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, ... Jose D. Debes
Ann Hepatol. 2023;28:100876
17
Full text access
15
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of actionAlexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
15
Full text access
11
Metabolic dysfunction: The silenced connection with fatty liver diseaseMariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
11
Full text access
10
Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosisHong Zhao, Wenyi Ye, Xia Yu, Jianhua Hu, Xuan Zhang, Meifang Yang, Jifang Sheng, Yu Shi
Ann Hepatol. 2023;28:100878
10
Full text access
10
Liver diseases: Perspective from the PhilippinesEric David Ornos, Karl Jeffrey Murillo, Janus P. Ong
Ann Hepatol. 2023;28:101085
10
Full text access